Ovid Therapeutics Inc.

SEC 4 · Filed

0001202098-26-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Apr 7, 2026

Grant, award or other acquisition by PAPADOPOULOS STELIOS

Security
Common Stock
Code
A
Shares
17,578
Price per share
2.56
Structured facts
{
  "code": "A",
  "date": "2026-04-07",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents a restricted stock unit (\"RSU\") award issued to the Reporting Person pursuant to the Issuer\u0027s Non-Employee Director Compensation Policy in lieu of an annual cash retainer for service on the Issuer\u0027s Board of Directors in the aggregate amount of $45,000. The RSUs vest 25% upon grant and 25% on each of June 30, 2026, September 30, 2026 and December 31, 2026, subject to the Reporting Person\u0027s continuous service through each such vesting date."
  },
  "owners": [
    {
      "cik": "0001202098",
      "name": "PAPADOPOULOS STELIOS",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "217578",
  "price": "2.56",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "17578",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}